콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO.
News
04/27/2021
<View Original Article>
Post Views:
145
Prev
Previous
PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect.
Next
PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards.
Next